Italian pediatric intensive care units admitting critically ill cancer children: results from a national survey.


Journal

Minerva anestesiologica
ISSN: 1827-1596
Titre abrégé: Minerva Anestesiol
Pays: Italy
ID NLM: 0375272

Informations de publication

Date de publication:
10 2023
Historique:
medline: 23 10 2023
pubmed: 28 6 2023
entrez: 28 6 2023
Statut: ppublish

Résumé

Pediatric patients affected by oncologic disease have a significant risk of clinical deterioration that requires admission to the intensive care unit. This study reported the results of a national survey describing the characteristics of Italian onco-hematological units (OHUs) and pediatric intensive care units (PICUs) that admit pediatric patients, focusing on the high-complexity treatments available before PICU admission, and evaluating the approach to the end-of-life (EOL) when cared in a PICU setting. A web-based electronic survey has been performed in April 2021, involving all Italian PICUs admitting pediatric patients with cancer participating in the study. Eighteen PICUs participated, with a median number of admissions per year of 350 (IQR 248-495). Availability of Extracorporeal Membrane Oxygenation therapy and the presence of intermediate care unit are the only statistically different characteristics between large or small PICUs. Different high-level treatments and protocols are performed in OHUs, non depending on the volume of PICU. Palliative sedation is mainly performed in the OHUs (78%), however, in 72% it is also performed in the PICU. In most centers protocols that address EOL comfort care and treatment algorithms are missing, non depending on PICU or OHU volume. A non-homogeneous availability of high-level treatments and in OHUs is described. Moreover, protocols addressing EOL comfort care and treatment algorithms in palliative care are lacking in many centers.

Sections du résumé

BACKGROUND
Pediatric patients affected by oncologic disease have a significant risk of clinical deterioration that requires admission to the intensive care unit. This study reported the results of a national survey describing the characteristics of Italian onco-hematological units (OHUs) and pediatric intensive care units (PICUs) that admit pediatric patients, focusing on the high-complexity treatments available before PICU admission, and evaluating the approach to the end-of-life (EOL) when cared in a PICU setting.
METHODS
A web-based electronic survey has been performed in April 2021, involving all Italian PICUs admitting pediatric patients with cancer participating in the study.
RESULTS
Eighteen PICUs participated, with a median number of admissions per year of 350 (IQR 248-495). Availability of Extracorporeal Membrane Oxygenation therapy and the presence of intermediate care unit are the only statistically different characteristics between large or small PICUs. Different high-level treatments and protocols are performed in OHUs, non depending on the volume of PICU. Palliative sedation is mainly performed in the OHUs (78%), however, in 72% it is also performed in the PICU. In most centers protocols that address EOL comfort care and treatment algorithms are missing, non depending on PICU or OHU volume.
CONCLUSIONS
A non-homogeneous availability of high-level treatments and in OHUs is described. Moreover, protocols addressing EOL comfort care and treatment algorithms in palliative care are lacking in many centers.

Identifiants

pubmed: 37378625
pii: S0375-9393.23.17329-9
doi: 10.23736/S0375-9393.23.17329-9
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

850-858

Investigateurs

Elena Barisone (E)
Francesco Bellia (F)
Tamara Belotti (T)
Veronica Biassoni (V)
Carolina Birolo (C)
Gabriella Bottari (G)
Alessandra Brugiolo (A)
Federica Carra (F)
Simone Cesaro (S)
Paola Coccia (P)
Manuela Corno (M)
Luigia D'Amato (L)
Paolo D'Angelo (P)
Nagua Giudici (N)
Daniela Guardo (D)
Francesca Izzo (F)
Giorgia Maiolo (G)
Ilaria Mascillini (I)
Angela Mastronuzzi (A)
Pietro Merli (P)
Andrea Pettenazzo (A)
Marta Pillon (M)
Simone Pizzi (S)
Monica Polini (M)
Fulvio Porta (F)
Massimo Provenzi (M)
Lucia Quaglietta (L)
Imma Rulli (I)
Fabio Savron (F)
Rita Scalisi (R)
Stefania Spaggiari (S)
Giacomo Tardini (G)
Gianluca Vigna (G)
Luisa Vatiero (L)
Giuseppina Zirilli (G)

Commentaires et corrections

Type : CommentIn

Auteurs

Matteo Martinato (M)

Unit of Biostatistics, Epidemiology and Public Health, Department of Cardiac, Thoracic, Vascular Sciences and Public Health, University of Padua, Padua, Italy.
Giuseppe Parenti Department of Statistics, Computer Science, Applications, University of Florence, Florence, Italy.

Rosanna I Comoretto (RI)

Unit of Biostatistics, Epidemiology and Public Health, Department of Cardiac, Thoracic, Vascular Sciences and Public Health, University of Padua, Padua, Italy.
Department of Sciences of Public Health and Pediatrics, University of Turin, Turin, Italy.

Paolo Biban (P)

University Hospital of Verona, Verona, Italy.

Elisa Zanonato (E)

S. Bortolo Hospital, Vicenza, Italy.

Alessandro Simonini (A)

Salesi Hospital, Ancona, Italy.

Alessia Montaguti (A)

IRCCS Giannina Gaslini Children Hospital, Genoa, Italy.

Eloisa Gitto (E)

University Hospital of Messina, Messina, Italy.

Fabio Caramelli (F)

S. Orsola-Malpighi IRCCS University Hospital, Bologna, Italy.

Stefania Ferrario (S)

Buzzi Children's Hospital, Milan, Italy.

Raffaella Sagredini (R)

IRCCS Burlo Garofalo Hospital, Trieste, Italy.

Nicola Alaimo (N)

Di Cristina Children's Hospital, Palermo, Italy.

Geremia Zito Marinosci (G)

Santobono Hospital, Naples, Italy.

Emanuele Rossetti (E)

ARCO Unit, Bambino Gesù Children's Hospital, Rome, Italy.

Corrado Cecchetti (C)

DEA Unit, Bambino Gesù Children's Hospital, Rome, Italy.

Manuela L'erario (M)

Meyer Children's Hospital of Florence, Florence, Italy.

Beatrice Vasile (B)

Spedali Civili, Brescia, Italy.

Giorgio Ivani (G)

AOU Città della Salute e della Scienza, Turin, Italy.

Ezio Bonanomi (E)

Papa Giovanni XXXIII Hospital, Bergamo, Italy.

Marinella Astuto (M)

Policlinico University Hospital of Catania, Catania, Italy.

Dario Gregori (D)

Unit of Biostatistics, Epidemiology and Public Health, Department of Cardiac, Thoracic, Vascular Sciences and Public Health, University of Padua, Padua, Italy.

Maria C Mondardini (MC)

S. Orsola-Malpighi IRCCS University Hospital, Bologna, Italy.

Angela Amigoni (A)

University Hospital of Padua, Padua, Italy - angela.amigoni@aaopd.veneto.it.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH